Loading...

PerCP/Cyanine5.5 anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_PerCPCy5dot5_011108
C57BL/6 mouse splenocytes stained with N418 PerCP/Cyanine5.5
  • N418_PerCPCy5dot5_011108
    C57BL/6 mouse splenocytes stained with N418 PerCP/Cyanine5.5
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
117327 25 µg 95€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117328 100 µg 259€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Denny L, et al. 2021. Clin Transl Immunology. 10:e1234. PubMed
  2. Feng J, et al. 2022. Immunity. 55:405. PubMed
  3. Dhalech AH, et al. 2022. J Virol. 96:e0123222. PubMed
  4. Chen X, et al. 2023. Adv Mater. 35:e2210440. PubMed
  5. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  6. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  7. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  8. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  9. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  10. Peters N, et al. 2012. J Immunol. 189:4832. PubMed
  11. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  12. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  13. Kobayashi T, et al. 2019. Cell. 176:982. PubMed
  14. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  15. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  16. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  17. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  18. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  19. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  20. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  21. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  22. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  23. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  24. Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
  25. Blijswijk J, et al. 2015. J Immunol. 194:307. PubMed
  26. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  27. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  28. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  29. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  30. Speth JM, et al. 2019. JCI Insight. 4:e131340. PubMed
  31. Bennion BG, et al. 2020. Cell Reports. 31(11):107771. PubMed
  32. Poczobutt J, et al. 2016. J Immunol. 196: 891 - 901. PubMed
  33. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  34. Liang Y, et al. 2014. J Immunol. 192:1277. PubMed
  35. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  36. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  37. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  38. Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
  39. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  40. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  41. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  42. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  43. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  44. Guo L, et al. 2021. Vaccines (Basel). 9:. PubMed
  45. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  46. Roberts LM, et al. 2021. iScience. 24:103025. PubMed
  47. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  48. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  49. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  50. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  51. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  52. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  53. Poczobutt J, et al. 2016. J Immunol. 196: 2847 - 2859. PubMed
  54. Steiger S, et al. 2015. J Immunol. 195: 5495 - 5502. PubMed
  55. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  56. Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
  57. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  58. Bastow CR, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  59. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  60. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  61. Ahn D, et al. 2021. Cell Reports. 35(9):109196. PubMed
  62. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  63. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  64. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  65. Peters N, et al. 2009. PLoS One. 5:e1000484. PubMed
  66. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  67. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  68. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  69. Hofmann J, et al. 2021. Front Immunol. 11:599495. PubMed
  70. Kitur K, et al. 2015. PLoS Pathog. 11:1004820. PubMed
  71. Xu J, et al. 2020. Immunity. 53(2):371-383.e5. PubMed
  72. Isvoranu G, et al. 2019. Oncol Lett. 17:4197. PubMed
  73. Dallari S, et al. 2021. Cell Host Microbe. 29(6):1014-1029.e8. PubMed
  74. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  75. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  76. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  77. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  78. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  79. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  80. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  81. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  82. Ren S, et al. 2022. Int J Biol Sci. 18:166. PubMed
  83. Dhayade S, et al. 2020. Nutrients. 12:. PubMed
  84. Hackstein CP, et al. 2022. Nat Commun. 13:7472. PubMed
  85. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  86. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  87. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  88. Sakamoto K, et al. 2022. STAR Protoc. 3:101052. PubMed
  89. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  90. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  91. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  92. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  93. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  94. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  95. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
RRID
AB_2129641 (BioLegend Cat. No. 117327)
AB_2129641 (BioLegend Cat. No. 117328)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account